fda warning bpc 157 unapproved peptide risks Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize – Partnership for Safe Medicines FDA's Overreach on Compounded Peptides
Description
Prescription-grade MIC + B12 designed to support steady, day-to-day energy and metabolic function with consistent use

At 48 weeks, the 8 mg group showed 22.8% mean body weight reduction, exceeding maximum tirzepatide dosing results
Acta Med Scand 204:8184

Those with cancer history should consult with their healthcare provider before considering use

My doctor said this was not a systemic reaction just a local reaction
Clinical trials and reports from individuals suggest AOD 9604 therapy has minimal to no significant side effects for most
